Stay updated on PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.

Latest updates to the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded Revision: v3.3.3 to the history. Removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page's revision changed from v3.3.1 to v3.3.2; no other content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe history shows additions of Revision: v3.3.1 and Results Submission Events set to 3, and removals of Revision: v3.2.0 and Results Submission Events set to 2.SummaryDifference0.2%

- Check51 days agoChange DetectedThe government funding notice banner was removed from the page.SummaryDifference0.6%

- Check65 days agoChange DetectedThe new screenshot shows a refreshed page layout and header; the underlying study record history content remains unchanged.SummaryDifference0.2%

- Check94 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference11%

Stay in the know with updates to PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-07265028 and Sasanlimab in Solid Tumors Clinical Trial page.